A 47-year-old dog breeder with chronic polyarthritis, weight loss and high fever;47-Jähriger hundezüchter mit chronischer polyarthritis, gewichtsverlust und hohem fieber

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 5, 2008, Pages 431-434

  Kremer, Andreas Emanuel ^a   Budenhofer, U ^b   Beuers, U ^a   Rust, C ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fever; Intestinal lipodystrophy; Seronegative polyarthritis; Tropheryma whipplii; Weight loss; Whipple's disease

Indexed keywords

ADALIMUMAB; COTRIMOXAZOLE; IMMUNOMODULATING AGENT; LEFLUNOMIDE;

ADULT; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; HUMAN; INTESTINE LIPODYSTROPHY; MALE; RHEUMATOID ARTHRITIS; TROPHERYMA WHIPPELII; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEVER OF UNKNOWN ORIGIN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; ISOXAZOLES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TROPHERYMA; WEIGHT LOSS; WHIPPLE DISEASE;

EID: 47649112088     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963690     Document Type: Article

References (22)

1. Fenollar F, Puéchal X, Raoult D. Whipple's disease. N Engl J Med 2007; 356: 55-66
2. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissue. Bull Johns Hopkins Hosp 1907; 18: 382-391
3. Black-Schaffer B. The tinctorial demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol Med 1949; 72: 225-227
4. Raoult D, Birg ML, La Scola B et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000; 342: 620-625
5. Bentley SD, Maiwald M, Murphy LD et al. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplii. Lancet 2003; 361: 637-644
6. Raoult D, Ogata H, Audic S et al. Tropheryma whipplii Twist: a human pathogenic Actinobacteria with a reduced genome. Genome Res 2003; 13: 1800-1809
7. Fenollar F, Fournier PE, Robert C et al. Use of genome selected repeated sequences increases the sensitivity of PCR detection of Tropheryma whipplii. J Clin Microbiol 2004; 42: 401-403
8. La Scola B, Fenollar F, Fournier PE et al. Description of Tropheryma whipplii gen. nov., sp. nov., the Whipple's disease bacillus. Int J Syst Evol Microbiol 2001; 51: 1471-1479
9. Desnues B, Ihrig M, Raoult D et al. Whipple's disease: a macrophage disease. Clin Vaccine Immunol 2006; 13: 170-178
10. Maiwald M, Schuhmacher F, Ditton HJ et al. Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 1998; 64: 760-762
11. Dobbins WO. Whipple's disease. Springfield, IL: Thomas, 1987
12. Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc 1988; 63: 539-551
13. Durand DV, Lecomte C, Cathebras P et al. Whipple disease: clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine 1997; 76: 170-184
14. Puéchal X. Whipple disease and arthritis. Curr Opin Rheumatol 2001; 13: 74-79
15. Gerard A, Sarrot-Reynauld F, Liozon E et al. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine 2002; 81: 443-457
16. Mahnel R, Kalt A, Ring S et al. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 2005; 100: 1167-1173
17. Mufti AH, Toye BW, Mckendrey RR et al. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. Diagn Microbiol Infect Dis 2005; 53: 233-238
18. Singh P, Taylor SF, Murali R et al. Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumour necrosis factor alpha inhibitor. Clin Experiment Ophthalmol 2007; 35: 275-280
19. Marth T, Neurath M, Cuccherini BA et al. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997; 113: 442-448
20. Schneider T, Stallmach A, von Herbay A et al. Treatment of refractory Whipple's disease with interferon-gamma. Ann Intern Med 1998; 129: 875-877
21. Kalt A, Schneider T, Ring S et al. Decreased levels of interleukin-12 p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis 2006; 21: 114-120
22. Müller SA, Vogt P, Altwegg M et al. Deadly carousel or difficult interpretation of new diagnostic tools for Whipple's disease: case report and review of the literature. Infection 2005; 33: 39-42